Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin Alone [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of dual add-on therapy with gemigliptin and dapagliflozin to metformin in type 2 diabetes patients with inade…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Gemigliptin (gemigliptin)
• metformin (metformin)

Snippet

Sponsor: LG Chem | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: UNKNOWN